AU2001223488A1 - Activators of peroxisome proliferator-activated alpha and beta receptors as medicaments for treating skin disorders having immunological causes - Google Patents
Activators of peroxisome proliferator-activated alpha and beta receptors as medicaments for treating skin disorders having immunological causesInfo
- Publication number
- AU2001223488A1 AU2001223488A1 AU2001223488A AU2348801A AU2001223488A1 AU 2001223488 A1 AU2001223488 A1 AU 2001223488A1 AU 2001223488 A AU2001223488 A AU 2001223488A AU 2348801 A AU2348801 A AU 2348801A AU 2001223488 A1 AU2001223488 A1 AU 2001223488A1
- Authority
- AU
- Australia
- Prior art keywords
- activators
- medicaments
- skin disorders
- peroxisome proliferator
- treating skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/DE2000/003955 WO2002038150A1 (en) | 2000-11-09 | 2000-11-09 | ACTIVATORS OF PEROXISOME PROLIFERATOR-ACTIVATED α AND β RECEPTORS AS MEDICAMENTS FOR TREATING SKIN DISORDERS HAVING IMMUNOLOGICAL CAUSES |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001223488A1 true AU2001223488A1 (en) | 2002-05-21 |
Family
ID=5648009
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001223488A Abandoned AU2001223488A1 (en) | 2000-11-09 | 2000-11-09 | Activators of peroxisome proliferator-activated alpha and beta receptors as medicaments for treating skin disorders having immunological causes |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1331934B1 (en) |
AU (1) | AU2001223488A1 (en) |
DE (1) | DE50012500D1 (en) |
WO (1) | WO2002038150A1 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005115370A2 (en) * | 2004-04-23 | 2005-12-08 | The Regents Of The University Of California | Compounds and methods for treating non-inflammatory pain using pparalpha agonists |
DE102004022253A1 (en) * | 2004-05-04 | 2005-12-08 | Phenion Gmbh & Co. Kg | Use of pirinixic acid and its salts for the treatment of chronic inflammatory diseases |
DE102007020554A1 (en) | 2007-04-27 | 2008-10-30 | Henkel Ag & Co. Kgaa | Nucleic acid-containing cosmetic and / or pharmaceutical preparations for the treatment of epithelial covering tissue |
DE102007044093A1 (en) | 2007-09-14 | 2009-03-19 | Phenion Gmbh & Co. Kg | Nucleic acid-containing cosmetic and / or pharmaceutical preparations for the induction of antimicrobial peptides in epithelial cover tissues |
ES2397889B1 (en) | 2011-03-25 | 2014-02-07 | Lipotec, S.A. | MODULATING PEPTIDES OF PGC-1 Alpha. |
DE202017105254U1 (en) | 2017-08-31 | 2017-09-19 | Jassen GmbH | Long-term transparent cosmetic preparations |
CN108992435A (en) * | 2018-07-10 | 2018-12-14 | 中国人民解放军第四军医大学 | Fenofibrate is preparing the application in Changes of Radiation Damaged Skin prevention and treatment externally applied drug |
IT202000027489A1 (en) * | 2020-11-17 | 2022-05-17 | Mauro Michele Maria Picardo | Selective activators of peroxisome proliferator-activated receptors (PPARs) for the treatment of vitiligo |
DE202021102468U1 (en) | 2021-05-06 | 2021-06-28 | ForMe Cosmetics GmbH i.G. | Multi-chamber system for storing and mixing components of cosmetic formulations |
DE102021111896A1 (en) | 2021-05-06 | 2022-11-10 | ForMe Cosmetics GmbH i.G. | Multi-chamber system for storing and mixing components of cosmetic formulations |
DE102021129474A1 (en) | 2021-11-11 | 2023-05-11 | Jassen GmbH | Cosmetic preparation for care and treatment of periocular skin |
DE202021106186U1 (en) | 2021-11-11 | 2021-12-14 | Jassen GmbH | Cosmetic preparation for care and treatment of periocular skin |
DE202021106362U1 (en) | 2021-11-22 | 2021-12-14 | Jassen GmbH | Cosmetic preparation for intensive care and treatment of facial skin |
DE202021106363U1 (en) | 2021-11-22 | 2021-12-15 | Jassen GmbH | Cosmetic preparation for the care and treatment of facial skin |
DE102021130543A1 (en) | 2021-11-22 | 2023-05-25 | Jassen GmbH | Cosmetic preparation for the care and treatment of facial skin |
DE102021130541A1 (en) | 2021-11-22 | 2023-05-25 | Jassen GmbH | Cosmetic preparation for intensive care and treatment of facial skin |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001509165A (en) * | 1997-01-24 | 2001-07-10 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | Use of FXR, PPARα and LXRα activators for restoring barrier function, promoting epidermal differentiation and inhibiting proliferation |
US6060515A (en) * | 1997-01-24 | 2000-05-09 | The Regents Of The University Of California | Treatment of skin conditions by use of PPARα activators |
FR2773075B1 (en) * | 1997-12-31 | 2000-05-05 | Cird Galderma | USE OF PPAR-GAMMA ACTIVATORS IN DERMATOLOGY |
US6071955A (en) * | 1999-02-25 | 2000-06-06 | The Regents Of The University Of California | FXR, PPARA and LXRA activators to treat acne/acneiform conditions |
GB9908647D0 (en) * | 1999-04-15 | 1999-06-09 | Smithkline Beecham Plc | Novel compounds |
DE10053003A1 (en) * | 1999-10-19 | 2001-06-28 | Univ Jw Goethe Frankfurt Main | Treatment of immunologically induced skin disorders, skin aging or neuropathy, comprises using peroxisome-proliferator activated receptor, alpha, beta activators such as pirinixic acid |
-
2000
- 2000-11-09 WO PCT/DE2000/003955 patent/WO2002038150A1/en active IP Right Grant
- 2000-11-09 AU AU2001223488A patent/AU2001223488A1/en not_active Abandoned
- 2000-11-09 EP EP00987112A patent/EP1331934B1/en not_active Expired - Lifetime
- 2000-11-09 DE DE50012500T patent/DE50012500D1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1331934B1 (en) | 2006-03-29 |
WO2002038150A1 (en) | 2002-05-16 |
DE50012500D1 (en) | 2006-05-18 |
EP1331934A1 (en) | 2003-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001223488A1 (en) | Activators of peroxisome proliferator-activated alpha and beta receptors as medicaments for treating skin disorders having immunological causes | |
AU2001278852A1 (en) | Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis | |
HUP9801599A3 (en) | Use of imidazolin derivatives having alfa1l agonist effect for producing pharmaceutical compositions for treatment of incontinence, novel imidazolin derivatives and process for producing them | |
IL127943A (en) | Pharmaceutical and cosmetic compositions for the treatment of skin disorders | |
AU7722600A (en) | Compositions and methods for the diagnosis and treatment of immune disorders | |
IL122733A0 (en) | Pharmaceutical compositions for use in the treatment of allergic asthma | |
IL147440A0 (en) | Composition for treatment of external secretion disorders | |
AU2001269046A1 (en) | Use of therapeutic benzamide derivatives | |
AU6919100A (en) | Compositions including modafinil for treatment of eating disorders and for appetite stimulation | |
AU7067200A (en) | Skin care compositions and treatments | |
AU2003223601A1 (en) | ANTI-INFLAMMATORY AND WOUND HEALING EFFECTS OF LYMPHOID THYMOSIN Beta 4 | |
AU2002240359A1 (en) | Pharmaceutical composition for the treatment of alopecia | |
AU5309600A (en) | Compositions and methods for the treatment and diagnosis of immune disorders | |
AU2001275707A1 (en) | Use of panaxatriol for stimulation angiogenesis | |
HUT60438A (en) | Application of inhaled non-steroid inflammation reducers for potentiation of antireactive, antiasthmatic effect of inhaled henle's loop-diuretics | |
HUP0001526A3 (en) | Use of nucleozides for producing pharmaceutical compositions for cytokine related treatments of disease and the pharmaceutical compositions | |
AU7106300A (en) | Treatment of skin disorders | |
EP1455780A4 (en) | Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma | |
AU3922900A (en) | Use of (valeriana) for the treatment of restless leg syndrome and related disorders | |
AU2003282626A1 (en) | Use of flavonoid for the treatment of overweight and the reduction of the mammalian appetite | |
AU3263795A (en) | Medicament for treatment or prophylaxis of incontinence | |
AU2002226060A1 (en) | Compositions containing gangliosides for use in the treatment of skin disorders | |
HUP0003634A3 (en) | Use of thiazolidinedione and sulphonylurea derivatives for the preparation of pharmaceutical compositions treating diabetes | |
AU7378400A (en) | Peroxisome proliferator-activated receptor alpha and disorders of lipid metabolism | |
AU1022501A (en) | Use of compositions for the caring treatment of the skin |